ArticlePattern recognition letters2026
Plug and Play Labeling Strategies for Boosting Small Brain Lesion Segmentation.
Article in Pattern recognition letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Accurate segmentation of small brain lesions in magnetic resonance imaging (MRI) is essential for understanding neurological disorders and guiding clinical decisions. However, detecting small lesions remains challenging due to low contrast and limited size. This study proposes two simple yet effective labeling strategies, Multi-Size Labeling (MSL) and Distance-Based Labeling (DBL), that can seamlessly integrate into existing segmentation networks. MSL groups lesions based on volume to enable size-aware learning, while DBL emphasizes lesion boundaries to enhance structural sensitivity. We evaluate our approach on two benchmark datasets: stroke lesion segmentation using the Anatomical Tracings of Lesions After Stroke (ATLAS) v2.0 dataset and multiple sclerosis lesion segmentation using the MSLesSeg dataset. On ATLAS v2.0, our approach achieved higher Dice (+1.3%), F1 (+2.4%), precision (+7.2%), and recall (+3.6%) scores compared to the top-performing method from a previous challenge. On MSLesSeg, our approach achieved the highest Dice score (0.7146) and ranked first among 16 international teams. Additionally, we examined the effectiveness of attention-based and mamba-based segmentation models but found that our proposed labeling strategies yielded more consistent improvements. These findings demonstrate that MSL and DBL offer a robust and generalizable solution for enhancing small brain lesion segmentation across various tasks and architectures. Our code is available at: https://github.com/nadluru/StrokeLesSeg.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.